Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial surface receptors and cell wall components represent a broad class of structural and functional molecules that define the bacterial envelope and mediate interactions with the environment and host organisms. This category includes the peptidoglycan scaffold, which provides osmotic stability; lipopolysaccharides (LPS) and teichoic acids, which contribute to surface charge and membrane integrity; and various surface proteins like porins, adhesins, and penicillin-binding proteins (PBPs) (Source: StatPearls, "Physiology, Bacterial Cell Wall"). These components are vital for bacterial viability and virulence, making them primary targets for many classes of antibiotics, such as beta-lactams, glycopeptides, and polymyxins (Source: NIH, "Antibiotics"). For example, beta-lactams inhibit PBPs to prevent cell wall cross-linking, leading to bacterial lysis, while polymyxins disrupt the outer membrane of Gram-negative bacteria by binding to LPS (Source: PubChem). Because many of these structures are unique to prokaryotes, they offer excellent therapeutic indices, though the development of resistance through target modification or efflux remains a major hurdle in treating bacterial infections (Source: WHO, "Antimicrobial resistance").
Drugs targeting these components typically act by inhibiting peptidoglycan cross-linking (e.g., beta-lactams), binding to the D-Ala-D-Ala terminus of peptidoglycan precursors (e.g., glycopeptides), or disrupting the outer membrane by binding to lipopolysaccharides (e.g., polymyxins) (Source: StatPearls, "Mechanism of Action of Antibiotics").
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial surface receptors and cell wall components.